Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07170540 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UNC Cashew Sublingual Immunotherapy

Study acronym: CASCADES
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Feb 2028 to Dec 2028 Start date: Jan 2026 to Jun 2026v4 Show 1 more changeShow less
    • Start date: Jan 2026 to Jun 2026
  2. Start date: Oct 2025 to Jan 2026v3
  3. Secondary endpoints revised (7)v2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The CASCADES study will investigate the safety and efficacy of sublingual immunotherapy (SLIT) for the treatment of cashew allergy in children ages 1-11 years old. Primary efficacy will be assessed after 18 months of cashew SLIT. Lab studies and an oral food challenge after 6 months of cashew SLIT will help determine how quickly cashew SLIT begins to take effect.
Trial Details
NCT Number NCT07170540
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: Food Allergy Research & Education
Conditions Cashew Nut Allergy, Tree Nut Allergies
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov